Abivax Income Statement (2021-2026) | ABVX

Income Statement Dec2021 Dec2022 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Operating items
Operating Interest Expenses (Quarter) 3.31M5.30M7.35M5.59M5.72M30.50M5.58M
Research & Development (Quarter) -49.28-111.04-38.83M-31.13M-47.54M-41.21M-41.34M-43.74M-64.78M-51.73M-58.00M
Selling, General & Administrative (Quarter) -7.65-24.10-8.84M-10.55M-8.10M-8.11M-8.45M-9.36M-29.81M-30.15M-7.36M
Restructuring Costs (Quarter) -13.88
Other Operating Expenses (Quarter) -2.15M-2.42M-0.94M395.29M-0.90M-0.76M-2.15M581.44M-2.05M
Operating Expenses (Quarter) -70.81-135.14-49.82M-44.10M-56.57M345.97M-50.69M-53.87M-96.75M499.57M-67.40M
Operating Income (Quarter) -66.11M-137.07M-48.53M-38.04M-55.12M-45.75M-49.65M-52.63M-94.36M-83.45M-65.83M
EBIT (Quarter) -66.11M-137.07M-48.53M-38.04M-55.12M-45.75M-49.65M-52.63M-94.36M-83.45M-65.83M
Non-operating items
Interest & Investment Income (Quarter) 6.55M3.89M3.77M4.04M1.63M3.96M23.85M5.59M14.94M
Non Operating Income (Quarter) 1.96M-3.71M-5.53M3.61M-5.44M-2.17M-84.93M-5.20M9.35M
Net income details
EBT (Quarter) -66.11M-137.07M-46.57M-41.75M-60.65M-42.03M-55.09M-54.80M-179.28M-88.65M-56.48M
Profit After Tax (Quarter) -61.93-158.5946.57M41.75M60.65M-334.54M55.09M54.80M179.28M-687.07M56.74M
Income from Continuing Operations (Quarter) -66.11M-137.07M-46.57M-41.75M-60.65M-42.03M-55.09M-54.80M-179.28M-88.65M-56.48M
Income from Discontinued Operations (Quarter) -6.75M-0.27M
Consolidated Net Income (Quarter) -66.11M-137.07M-46.57M-41.75M-60.65M-42.03M-55.09M-54.80M-179.28M-95.40M-56.74M
Income towards Parent Company (Quarter) -66.11M-137.07M-46.57M-41.75M-60.65M-42.03M-55.09M-54.80M-179.28M-95.40M-56.74M
Net Income towards Common Stockholders (Quarter) -66.11M-137.07M-46.57M-41.75M-60.65M-42.03M-55.09M-54.80M-179.28M-95.40M-56.74M
Additional items
EPS (Basic) (Quarter) -3.46-3.18-0.74-0.66-0.96-0.67-0.87-0.86-2.46-1.37-0.72
EPS (Diluted) (Quarter) -3.46-3.18-0.74-0.66-0.96-0.67-0.87-0.86-2.46-1.37-0.72
Shares Outstanding (Quarter) 15.46M19.09M43.07M62.92M62.92M63.23M63.05M63.38M63.44M72.94M69.53M78.96M
Shares Outstanding (Diluted) (Quarter) 15.46M19.09M43.07M62.92M62.92M63.23M63.05M63.38M63.44M72.94M69.53M78.96M
EBITDA (Quarter) -66.11M-137.07M-48.53M-38.04M-55.12M-45.75M-49.65M-52.63M-94.36M-83.45M-65.83M
Interest Expenses (Quarter) -4.59M-7.60M-9.31M23.89M-7.07M-6.13M-108.78M-0.66M-5.58M